ORIENT BIO Inc.

KSE 002630.KS

ORIENT BIO Inc. Market Capitalization on January 14, 2025: USD 139.97 M

ORIENT BIO Inc. Market Capitalization is USD 139.97 M on January 14, 2025, a 162.45% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

ORIENT BIO Inc. 52-week high Market Capitalization is USD 151.86 M on December 13, 2024, which is 8.49% above the current Market Capitalization.
ORIENT BIO Inc. 52-week low Market Capitalization is USD 34.71 M on November 15, 2024, which is -75.20% below the current Market Capitalization.
ORIENT BIO Inc. average Market Capitalization for the last 52 weeks is USD 51.67 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

KSE: 002630.KS

ORIENT BIO Inc.

CEO	Mr. Jae-Jin Chang
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	322, Galmachi-ro
Employees	125
Sector	Health Care
Industries Biotechnology

Description

ORIENT BIO Inc. operates in the bio-industry in South Korea. The company produces laboratory animals. In addition, it offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam, South Korea.

Key trends

Past 5 years